Regenicin Inc Stock OTC Bulletin Board
Equities
US75887Q1022
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 491K |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 | - |
Net Debt 2021 | 598K | Net Debt 2022 | 627K | EV / Sales 2022 | - |
P/E ratio 2021 |
-2
x | P/E ratio 2022 |
-0.71
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.1% |
Managers | Title | Age | Since |
---|---|---|---|
Randall McCoy
CEO | Chief Executive Officer | 74 | 10-07-14 |
John Weber
DFI | Director of Finance/CFO | 74 | 10-09-12 |
J. Nelson
CTO | Chief Tech/Sci/R&D Officer | 75 | 10-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Weber
DFI | Director of Finance/CFO | 74 | 10-09-12 |
Randall McCoy
CEO | Chief Executive Officer | 74 | 10-07-14 |
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.10% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |